JO
FLNA

John Overdeck’s Filana Therapeutics FLNA Stock Holding History

John Overdeck’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Sell
1,711,358
-277,456
-14% -$395K ﹤0.01% 2983
2026
Q1 		$3.36M Buy
1,988,814
+1,346,413
+210% +$2.77M ﹤0.01% 2348
2025
Q4 		$1.27M Buy
642,401
+77,403
+14% +$248K ﹤0.01% 2760
2025
Q3 		$1.64M Buy
564,998
+38,483
+7% +$88.5K ﹤0.01% 2260
2025
Q2 		$953K Buy
526,515
+93,934
+22% +$167K ﹤0.01% 2285
2025
Q1 		$649K Sell
432,581
-129,501
-23% -$327K ﹤0.01% 2400
2024
Q4 		$1.33M Buy
562,082
+489,936
+679% +$8.6M ﹤0.01% 1990
2024
Q3 		$2.12M Buy
72,146
+53,393
+285% +$1.23M ﹤0.01% 1646
2024
Q2 		$232K Buy
+18,753
New +$395K ﹤0.01% 2689
2020
Q2 		– Sell
-22,269
Closed -$92K – 3453
2020
Q1 		$92K Sell
22,269
-57,798
-72% -$383K ﹤0.01% 2858
2019
Q4 		$416K Buy
+80,067
New +$138K ﹤0.01% 2938
2015
Q3 		– Sell
-2,920
Closed -$35K – 2663
2015
Q2 		$35K Buy
+2,920
New +$40K ﹤0.01% 2742
2015
Q1 		– Sell
-5,767
Closed -$82K – 2824
2014
Q4 		$82K Buy
+5,767
New +$99.8K ﹤0.01% 2145
2014
Q3 		– Sell
-14,453
Closed -$582K – 2012
2014
Q2 		$582K Buy
14,453
+6,587
+84% +$244K ﹤0.01% 1540
2014
Q1 		$303K Buy
7,866
+3,652
+87% +$129K ﹤0.01% 1676
2013
Q4 		$143K Buy
+4,214
New +$112K ﹤0.01% 2049

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

John Overdeck's FLNA Position: Q2 2026 in Review

John Overdeck reduced its Filana Therapeutics (FLNA) stake by 14% in Q2 2026, selling an estimated $395K and leaving 1,711,358 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

John Overdeck first reported a position in FLNA in Q4 2013 and has held it in 16 quarters since. The position peaked at $3.36M in Q1 2026. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • John Overdeck held 1,711,358 shares of Filana Therapeutics worth $2.04M as of Q2 2026.
  • John Overdeck sold 277,456 Filana Therapeutics shares in Q2 2026, an estimated $395K.
  • Filana Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2983 holding.
  • John Overdeck first reported a position in Filana Therapeutics in Q4 2013 and has held it in 16 quarters since.
  • John Overdeck's Filana Therapeutics position peaked at $3.36M in Q1 2026.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.